Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Injectables Market Segmentation
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary
2. Global Injectables Market Introduction
2.1. Global Injectables Market - Taxonomy
2.2. Global Injectables Market - Definitions
2.2.1. By Type
2.2.2. By Route of Administration
2.2.3. By Application
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Injectables Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Injectables Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Devices/Container
4.1.1. Ampoules
4.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.1.3. Market Opportunity Analysis
4.1.2. Vials
4.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.2.3. Market Opportunity Analysis
4.1.3. Cartridges
4.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3.3. Market Opportunity Analysis
4.1.4. Bottles
4.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.4.3. Market Opportunity Analysis
4.1.5. Others
4.1.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.5.3. Market Opportunity Analysis
4.2. Formulations
4.2.1. Small Molecule
4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.1.3. Market Opportunity Analysis
4.2.2. Biologics
4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.2.3. Market Opportunity Analysis
5. Global Injectables Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Intravenous (IV)
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Intramuscular (IM)
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Subcutaneous (SC)
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Injectables Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Oncology
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Neurology
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cardiovascular Diseases
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Autoimmune Diseases
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Infectious Diseases
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Pain
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Injectables Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospital Pharmacy
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacy
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Online Pharmacy
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Injectables Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Injectables Market - Opportunity Analysis Index, By Route of Administration, Type, Application, Distribution Channel, and Region, 2023-2029
9. North America Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Devices/Container
9.1.1.1. Ampoules
9.1.1.2. Vials
9.1.1.3. Cartridges
9.1.1.4. Bottles
9.1.1.5. Others
9.1.2. Formulations
9.1.2.1. Small Molecule
9.1.2.2. Biologics
9.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Intravenous (IV)
9.2.2. Intramuscular (IM)
9.2.3. Subcutaneous (SC)
9.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. Oncology
9.3.2. Neurology
9.3.3. Cardiovascular Diseases
9.3.4. Autoimmune Diseases
9.3.5. Infectious Diseases
9.3.6. Pain
9.3.7. Others
9.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.4.1. Hospital Pharmacy
9.4.2. Retail Pharmacy
9.4.3. Online Pharmacy
9.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.5.1. USA
9.5.2. Canada
10. Europe Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Devices/Container
10.1.1.1. Ampoules
10.1.1.2. Vials
10.1.1.3. Cartridges
10.1.1.4. Bottles
10.1.1.5. Others
10.1.2. Formulations
10.1.2.1. Small Molecule
10.1.2.2. Biologics
10.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Intravenous (IV)
10.2.2. Intramuscular (IM)
10.2.3. Subcutaneous (SC)
10.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. Oncology
10.3.2. Neurology
10.3.3. Cardiovascular Diseases
10.3.4. Autoimmune Diseases
10.3.5. Infectious Diseases
10.3.6. Pain
10.3.7. Others
10.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospital Pharmacy
10.4.2. Retail Pharmacy
10.4.3. Online Pharmacy
10.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.5.1. Germany
10.5.2. France
10.5.3. Italy
10.5.4. Spain
10.5.5. UK
10.5.6. Rest of Europe
11. Asia Pacific Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Devices/Container
11.1.1.1. Ampoules
11.1.1.2. Vials
11.1.1.3. Cartridges
11.1.1.4. Bottles
11.1.1.5. Others
11.1.2. Formulations
11.1.2.1. Small Molecule
11.1.2.2. Biologics
11.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Intravenous (IV)
11.2.2. Intramuscular (IM)
11.2.3. Subcutaneous (SC)
11.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Oncology
11.3.2. Neurology
11.3.3. Cardiovascular Diseases
11.3.4. Autoimmune Diseases
11.3.5. Infectious Diseases
11.3.6. Pain
11.3.7. Others
11.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospital Pharmacy
11.4.2. Retail Pharmacy
11.4.3. Online Pharmacy
11.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.5.1. China
11.5.2. Japan
11.5.3. South Korea
11.5.4. India
11.5.5. Rest of APAC
12. Latin America Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.1.1. Devices/Container
12.1.1.1. Ampoules
12.1.1.2. Vials
12.1.1.3. Cartridges
12.1.1.4. Bottles
12.1.1.5. Others
12.1.2. Formulations
12.1.2.1. Small Molecule
12.1.2.2. Biologics
12.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.2.1. Intravenous (IV)
12.2.2. Intramuscular (IM)
12.2.3. Subcutaneous (SC)
12.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.3.1. Oncology
12.3.2. Neurology
12.3.3. Cardiovascular Diseases
12.3.4. Autoimmune Diseases
12.3.5. Infectious Diseases
12.3.6. Pain
12.3.7. Others
12.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospital Pharmacy
12.4.2. Retail Pharmacy
12.4.3. Online Pharmacy
12.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
13. MEA Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.1.1. Devices/Container
13.1.1.1. Ampoules
13.1.1.2. Vials
13.1.1.3. Cartridges
13.1.1.4. Bottles
13.1.1.5. Others
13.1.2. Formulations
13.1.2.1. Small Molecule
13.1.2.2. Biologics
13.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.2.1. Intravenous (IV)
13.2.2. Intramuscular (IM)
13.2.3. Subcutaneous (SC)
13.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.3.1. Oncology
13.3.2. Neurology
13.3.3. Cardiovascular Diseases
13.3.4. Autoimmune Diseases
13.3.5. Infectious Diseases
13.3.6. Pain
13.3.7. Others
13.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospital Pharmacy
13.4.2. Retail Pharmacy
13.4.3. Online Pharmacy
13.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Becton, Dickinson and Company
14.2.2. Novo Nordisk AS
14.2.3. Amgen Inc.
14.2.4. Baxter International Inc.
14.2.5. Gilead Sciences Inc.
14.2.6. GlaxoSmithKline PLC
14.2.7. Johnson & Johnson
14.2.8. Merck & Co. Inc.
14.2.9. Novartis AG
14.2.10. Pfizer Inc.
14.2.11. Sanofi SA
14.2.12. AbbVie
14.2.13. F. Hoffmann-La Roche Ltd
15. Research Methodology
16. Key Assumptions and Acronyms
2. Global Injectables Market Introduction
2.1. Global Injectables Market - Taxonomy
2.2. Global Injectables Market - Definitions
2.2.1. By Type
2.2.2. By Route of Administration
2.2.3. By Application
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Injectables Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Injectables Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Devices/Container
4.1.1. Ampoules
4.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.1.3. Market Opportunity Analysis
4.1.2. Vials
4.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.2.3. Market Opportunity Analysis
4.1.3. Cartridges
4.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3.3. Market Opportunity Analysis
4.1.4. Bottles
4.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.4.3. Market Opportunity Analysis
4.1.5. Others
4.1.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.5.3. Market Opportunity Analysis
4.2. Formulations
4.2.1. Small Molecule
4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.1.3. Market Opportunity Analysis
4.2.2. Biologics
4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.2.3. Market Opportunity Analysis
5. Global Injectables Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Intravenous (IV)
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Intramuscular (IM)
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Subcutaneous (SC)
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Injectables Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Oncology
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Neurology
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cardiovascular Diseases
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Autoimmune Diseases
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Infectious Diseases
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Pain
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Injectables Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospital Pharmacy
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacy
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Online Pharmacy
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Injectables Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Injectables Market - Opportunity Analysis Index, By Route of Administration, Type, Application, Distribution Channel, and Region, 2023-2029
9. North America Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Devices/Container
9.1.1.1. Ampoules
9.1.1.2. Vials
9.1.1.3. Cartridges
9.1.1.4. Bottles
9.1.1.5. Others
9.1.2. Formulations
9.1.2.1. Small Molecule
9.1.2.2. Biologics
9.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Intravenous (IV)
9.2.2. Intramuscular (IM)
9.2.3. Subcutaneous (SC)
9.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. Oncology
9.3.2. Neurology
9.3.3. Cardiovascular Diseases
9.3.4. Autoimmune Diseases
9.3.5. Infectious Diseases
9.3.6. Pain
9.3.7. Others
9.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.4.1. Hospital Pharmacy
9.4.2. Retail Pharmacy
9.4.3. Online Pharmacy
9.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.5.1. USA
9.5.2. Canada
10. Europe Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Devices/Container
10.1.1.1. Ampoules
10.1.1.2. Vials
10.1.1.3. Cartridges
10.1.1.4. Bottles
10.1.1.5. Others
10.1.2. Formulations
10.1.2.1. Small Molecule
10.1.2.2. Biologics
10.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Intravenous (IV)
10.2.2. Intramuscular (IM)
10.2.3. Subcutaneous (SC)
10.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. Oncology
10.3.2. Neurology
10.3.3. Cardiovascular Diseases
10.3.4. Autoimmune Diseases
10.3.5. Infectious Diseases
10.3.6. Pain
10.3.7. Others
10.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospital Pharmacy
10.4.2. Retail Pharmacy
10.4.3. Online Pharmacy
10.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.5.1. Germany
10.5.2. France
10.5.3. Italy
10.5.4. Spain
10.5.5. UK
10.5.6. Rest of Europe
11. Asia Pacific Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Devices/Container
11.1.1.1. Ampoules
11.1.1.2. Vials
11.1.1.3. Cartridges
11.1.1.4. Bottles
11.1.1.5. Others
11.1.2. Formulations
11.1.2.1. Small Molecule
11.1.2.2. Biologics
11.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Intravenous (IV)
11.2.2. Intramuscular (IM)
11.2.3. Subcutaneous (SC)
11.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Oncology
11.3.2. Neurology
11.3.3. Cardiovascular Diseases
11.3.4. Autoimmune Diseases
11.3.5. Infectious Diseases
11.3.6. Pain
11.3.7. Others
11.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospital Pharmacy
11.4.2. Retail Pharmacy
11.4.3. Online Pharmacy
11.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.5.1. China
11.5.2. Japan
11.5.3. South Korea
11.5.4. India
11.5.5. Rest of APAC
12. Latin America Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.1.1. Devices/Container
12.1.1.1. Ampoules
12.1.1.2. Vials
12.1.1.3. Cartridges
12.1.1.4. Bottles
12.1.1.5. Others
12.1.2. Formulations
12.1.2.1. Small Molecule
12.1.2.2. Biologics
12.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.2.1. Intravenous (IV)
12.2.2. Intramuscular (IM)
12.2.3. Subcutaneous (SC)
12.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.3.1. Oncology
12.3.2. Neurology
12.3.3. Cardiovascular Diseases
12.3.4. Autoimmune Diseases
12.3.5. Infectious Diseases
12.3.6. Pain
12.3.7. Others
12.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospital Pharmacy
12.4.2. Retail Pharmacy
12.4.3. Online Pharmacy
12.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
13. MEA Injectables Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.1.1. Devices/Container
13.1.1.1. Ampoules
13.1.1.2. Vials
13.1.1.3. Cartridges
13.1.1.4. Bottles
13.1.1.5. Others
13.1.2. Formulations
13.1.2.1. Small Molecule
13.1.2.2. Biologics
13.2. Route of Administration Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.2.1. Intravenous (IV)
13.2.2. Intramuscular (IM)
13.2.3. Subcutaneous (SC)
13.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.3.1. Oncology
13.3.2. Neurology
13.3.3. Cardiovascular Diseases
13.3.4. Autoimmune Diseases
13.3.5. Infectious Diseases
13.3.6. Pain
13.3.7. Others
13.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospital Pharmacy
13.4.2. Retail Pharmacy
13.4.3. Online Pharmacy
13.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Becton, Dickinson and Company
14.2.2. Novo Nordisk AS
14.2.3. Amgen Inc.
14.2.4. Baxter International Inc.
14.2.5. Gilead Sciences Inc.
14.2.6. GlaxoSmithKline PLC
14.2.7. Johnson & Johnson
14.2.8. Merck & Co. Inc.
14.2.9. Novartis AG
14.2.10. Pfizer Inc.
14.2.11. Sanofi SA
14.2.12. AbbVie
14.2.13. F. Hoffmann-La Roche Ltd
15. Research Methodology
16. Key Assumptions and Acronyms
Becton, Dickinson and Company
Novo Nordisk AS
Amgen Inc.
Baxter International Inc.
Gilead Sciences Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi SA
AbbVie
F. Hoffmann-La Roche Ltd
Novo Nordisk AS
Amgen Inc.
Baxter International Inc.
Gilead Sciences Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi SA
AbbVie
F. Hoffmann-La Roche Ltd